Diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome of the liver: problems of interpretation.

Suppr

超能文献

作者信息

Volin L, Niittyvuopio R, Heiskanen J, Lindström V, Nihtinen A, Sahlstedt L, Ruutu T

机构信息

Helsinki University Hospital, Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.

出版信息

Bone Marrow Transplant. 2016 Dec;51(12):1633-1635. doi: 10.1038/bmt.2016.237. Epub 2016 Sep 26.

DOI:10.1038/bmt.2016.237

PMID:27668765

Abstract

摘要

相似文献

Diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome of the liver: problems of interpretation.

Bone Marrow Transplant. 2016 Dec;51(12):1633-1635. doi: 10.1038/bmt.2016.237. Epub 2016 Sep 26.

Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation.

Exp Mol Pathol. 2015 Feb;98(1):73-8. doi: 10.1016/j.yexmp.2014.12.008. Epub 2014 Dec 20.

BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17.

Does fludarabine increase the incidence of sinusoidal obstruction syndrome when combined with Bu/Cy during conditioning?

Clin Transplant. 2012 Mar-Apr;26(2):E85-6. doi: 10.1111/j.1399-0012.2012.01616.x. Epub 2012 Mar 20.

[Usefulness of serum plasminogen activator inhibitor-1 for diagnosis and monitoring of late-onset sinusoidal obstruction syndrome after allogeneic stem cell transplantation].

Rinsho Ketsueki. 2010 Jan;51(1):69-73.

Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation.

Ann Hematol. 2005 May;84(5):321-30. doi: 10.1007/s00277-004-0982-4. Epub 2004 Dec 4.

Allogeneic hematopoietic cell transplantation in systemic mastocytosis: is there a high risk for veno-occlusive disease?

Eur J Haematol. 2016 Jun;96(6):655-7. doi: 10.1111/ejh.12720. Epub 2016 Jan 22.

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.

Bone Marrow Transplant. 2001 Oct;28(7):643-7. doi: 10.1038/sj.bmt.1703215.

Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning.

Int J Hematol. 2015 Dec;102(6):729-31. doi: 10.1007/s12185-015-1878-x.

How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation.

Br J Haematol. 2015 Feb;168(4):481-91. doi: 10.1111/bjh.13215. Epub 2014 Nov 17.

引用本文的文献

Precision Glycan Supplementation Improves Gut Microbiota Diversity, Performance, and Disease Outbreak Resistance in Broiler Chickens.

Animals (Basel). 2023 Dec 21;14(1):32. doi: 10.3390/ani14010032.

Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation.

Haematologica. 2021 Sep 1;106(9):2374-2383. doi: 10.3324/haematol.2019.245407.

本文引用的文献

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.

Bone Marrow Transplant. 2016 Jul;51(7):906-12. doi: 10.1038/bmt.2016.130. Epub 2016 May 16.

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT).

Bone Marrow Transplant. 2015 Jun;50(6):781-9. doi: 10.1038/bmt.2015.52. Epub 2015 Mar 23.

How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation.

Br J Haematol. 2015 Feb;168(4):481-91. doi: 10.1111/bjh.13215. Epub 2014 Nov 17.

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Lancet. 2012 Apr 7;379(9823):1301-9. doi: 10.1016/S0140-6736(11)61938-7. Epub 2012 Feb 23.

Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant. 2007 Feb;13(2):206-17. doi: 10.1016/j.bbmt.2006.09.012.

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.

Blood. 2002 Sep 15;100(6):1977-83. doi: 10.1182/blood-2001-12-0159.

Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.

Blood. 2000 Oct 1;96(7):2391-8.

On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease.

Ann Hematol. 1993 Feb;66(2):77-80. doi: 10.1007/BF01695888.

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.

Ann Intern Med. 1993 Feb 15;118(4):255-67. doi: 10.7326/0003-4819-118-4-199302150-00003.

Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.

Hepatology. 1984 Jan-Feb;4(1):116-22. doi: 10.1002/hep.1840040121.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验